Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer
Condition: Locally Advanced Unresectable Gastric Adenocarcinoma Interventions: Drug: Oxaliplatin; Drug: Capecitabine; Drug: Cadonilimab Sponsor: Tianjin Medical University Cancer Institute and Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Research | Xeloda